Clinical trial

Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

University of ZurichCompletedPhase 2Started Jun 8, 202037 enrolledSwitzerlandNCT04141501

Abstract

Effects of serotonin 2A/1A receptor stimulation by psilocybin on alcohol addicted patients: a randomized double-blind placebo-controlled study

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAddiction

Keywords

AlcoholismPsychedelicsclinical efficacyautobiographical memorycue-reactivity exposureplacebo-controlledproof-of-conceptAlcohol Use Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

This study's objects

Directly linked records, matched by DOI, trial reference, or registry, not just topic.

Publications from this trial

ArticlePsilocybin

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.

Rieser NM, Bitar R, Halm S +14

Europe PMC2025

Related research

PreprintPsilocybin

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making

Mitina O, Mirsaidov M, Molchanova N +1

Europe PMC2020

ArticlePsilocybin

Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.

Zhang W, Hwang SY, Luther J

Europe PMC2025

ArticlePsilocybin

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey.

Glynos NG, Aday JS, Kruger D +3

Europe PMC2024